Development of Medications for the Treatment of Opiate and Cocaine Addictions

Pharmacotherapy, as a means of treating drug addiction in combination with other treatment modalities, has received too little attention from the research community, the pharmaceutical industry, public health officials, and the federal government. Medications to combat drug addiction could have an enormous impact on the medical consequences and socioeconomic problems associated with drug abuse, both for drug-dependent individuals and for American society as a whole. This book examines the current environment for and obstacles to the development of anti-addiction medications, specifically those for treating opiate and cocaine addictions, and proposes incentives for the pharmaceutical industry that would help overcome those obstacles and accelerate the development of anti-addiction medications.Table of ContentsFront MatterExecutive Summary1 Introduction2 Overview of the State of Scientific Knowledge Concerning Drug Addiction3 Assessment of the Medications Development Division4 Treatment Setting and Effectiveness5 Treatment Financing and Trends in Health Insurance6 Training and Education7 Federal Laws and Regulations8 State Laws and Regulations9 Market Obstacles and Creating IncentivesAppendix A: AcknowledgmentsAppendix B: Organization and Mission Statements of NIDA's Medications Development Division and Its BranchesAppendix C: Diagnostic Criteria for Psychoactive Substance DependenceAppendix D: Survey of Pharmaceutical CompaniesAppendix E: Model Federal Programs in Pharmaceutical R&DAppendix F: Workshop Agenda and ParticipantsAppendix G: Health Care Reform LegislationAppendix H: Acronyms